Adapalene

규격

106685-40-9CAS 번호

620-513-9EC 번호

6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acidIUPAC 명칭

C28H28O3화학식

412.5 g/mol분자량

ADAPALENE; 106685-40-9; Differin; Adapaleno; Adapalenum; Adaferin; CD-271; CD 271; Differine; 6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid; 6-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoic acid; DTXSID5046481; 1L4806J2QF; 6-(4-Methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-2-naphthalenecarboxylic acid; 6-[3-(adamantan-1-yl)-4-methoxyphenyl]naphthalene-2-carboxylic acid; IDP-126 Component Adapalene; DTXCID3026481; CHEBI:31174; CABTREO COMPONENT ADAPALENE; 2-Naphthalenecarboxylic acid, 6-(4-methoxy-3-tricyclo(3.3.1.1(sup 3,7))dec-1-ylphenyl)-; CD271; Adaplaene; Effaclar; Adapalene Gel; 6-(3-(adamantan-1-yl)-4-methoxyphenyl)naphthalene-2-carboxylic acid; Proactiv MD Kit; 6-(4-Methoxy-3-tricyclo(3.3.1.13,7)dec-1-ylphenyl)-2-naphthalenecarboxylic Acid; Curist Acne Relief; MD Kit; Adaplane 0.1%; Proactiv MD Adapalene; Adapalene Gel 0.1%; RefChem:53995; Adapalene Topical Solution; Adapalene Gel USP, 0.3%; D10AD03; Proactiv MD Adapalene Acne Treatment; 271, CD; Neutrogena Adapalene 0.1% Acne Treatment; 620-513-9; 6-(3-(Adamantan-1-yl)-4-methoxyphenyl)-2-naphthoic acid; Adapalenum [INN-Latin]; Adapaleno [INN-Spanish]; 6-[3-(1-adamantyl)-4-methoxy-phenyl]naphthalene-2-carboxylic acid; 6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid; C28H28O3; MFCD03106112; CHEMBL1265; 6-(3-adamantan-1-yl-4-methoxyphenyl)naphthalene-2-carboxylic acid; NCGC00164617-01; Adapalen; Differin Gel; 6-(3-((3r,5r,7r)-adamantan-1-yl)-4-methoxyphenyl)-2-naphthoic acid; Differin (TN); CAS-106685-40-9; Differin Gel 0.1%; Adapelene; Adapalene [USAN:INN:BAN]; UNII-1L4806J2QF; Adapalene CRS; Adapalene; 6-(4-Methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)naphthalene-2-carboxylic acid; Adapalene (Standard); KS-1196; ADAPALENE [INN]; ADAPALENE [JAN]; ADAPALENE [MI]; ADAPALENE [USAN]; ADAPALENE [VANDF]; ADAPALENE [MART.]; ADAPALENE [USP-RS]; ADAPALENE [WHO-DD]; SCHEMBL2747; Adapalene (JAN/USP/INN); MLS000759463; MLS006010036; orb746767; BIDD:GT0264; Adapalene - Bio-X trade mark; GTPL5429; orb1227043; orb1309802; orb3025950; ADAPALENE [ORANGE BOOK]; ADAPALENE [EP MONOGRAPH]; Adapalene, >=98% (HPLC); CHEMBL4303650; SCHEMBL26688757; SCHEMBL29356474; SCHEMBL29357372; SCHEMBL29393098; SCHEMBL29688458; EPIDUO COMPONENT ADAPALENE; HY-B0091R; ADAPALENE [USP MONOGRAPH]; HMS3264F15; HMS3654F11; HMS3715H16; HMS3754C15; HMS5079F05; HY-B0091; Tox21_112236; BDBM50048280; EBC-27000; MSK159098; s1276; Adapalene for peak identification CRS; AKOS005145841; AKOS015895391; Tox21_112236_1; AB13763; AC-1974; CCG-213060; CCG-221237; CS-1789; DB00210; FA17220; NCGC00164617-02; NCGC00164617-04; NCGC00164617-05; NCGC00164617-12; BA164138; PD119179; SMR000466349; SMR002529673; SY009767; A2549; NS00010470; SW219282-1; D01112; SBI-0653441.0001; SBI-0653441.0002; AB01274764-01; AB01274764-02; AB01274764_03; AB01274764_04; EN300-19997240; Q352348; SR-01000942194; SR-01000942194-2; BRD-K33127281-001-01-5; BRD-K33127281-001-04-9; BRD-K33127281-001-05-6; F2173-0588; 6-(3-(Adamantan-1-yl)-4-methoxyphenyl)-2-naphthoicacid; Adapalene 100 microg/mL in Acetonitrile:Dimethylsulfoxide; Adapalene, European Pharmacopoeia (EP) Reference Standard; Adapalene, United States Pharmacopeia (USP) Reference Standard; 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthalene-carboxylic acid; 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthalenecarboxylic acid; Adapalene, Pharmaceutical Secondary Standard; Certified Reference Material; Adapalene for peak identification, European Pharmacopoeia (EP) Reference Standard; 2-NAPHTHALENECARBOXYLIC ACID, 6-(4-METHOXY-3-TRICYCLO(3.3.1.(SUP 13,7))DEC-1-YLPHENYL)-동의어